Document Detail


Pellagra secondary to 5-fluorouracil.
MedLine Citation:
PMID:  8504053     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The development of pellagra in a patient treated with 5-fluorouracil for malignant disease is reported. The aetiology of pellagra in this patient is discussed, and the reasons for possible under-diagnosis of pellagra in association with malignant disease considered. We report a patient who presented with the typical skin changes of pellagra. The rash, and an associated acute deterioration in cerebral function, were exacerbated by treatment with 5-fluorouracil. The importance of considering nicotinic-acid deficiency in patients with malignant disease has not been emphasized in the literature.
Authors:
H P Stevens; L S Ostlere; R H Begent; J S Dooley; M H Rustin
Related Documents :
22154043 - Thrombotic thrombocytopenic purpura and its look-alikes: a single institution experience.
3977973 - Prognostic factors in polymyositis/dermatomyositis. a computer-assisted analysis of nin...
21398103 - Elevated peripheral airway nitric oxide in bronchiectasis reflects disease severity.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  The British journal of dermatology     Volume:  128     ISSN:  0007-0963     ISO Abbreviation:  Br. J. Dermatol.     Publication Date:  1993 May 
Date Detail:
Created Date:  1993-07-07     Completed Date:  1993-07-07     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0004041     Medline TA:  Br J Dermatol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  578-80     Citation Subset:  IM    
Affiliation:
Department of Dermatology, Royal Free Hospital and School of Medicine, London, U.K.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Biliary Tract Neoplasms / drug therapy
Fluorouracil / adverse effects*,  therapeutic use
Humans
Liver Neoplasms / drug therapy,  secondary
Male
Nicotinic Acids / therapeutic use
Pellagra / chemically induced*,  drug therapy,  pathology
Skin / pathology
Chemical
Reg. No./Substance:
0/Nicotinic Acids; 51-21-8/Fluorouracil

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Topical calcitriol in the treatment of chronic plaque psoriasis: a double-blind study.
Next Document:  Antibody engineering using Escherichia coli as host.